Clearview Wealth Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Clearview Wealth Advisors's AMGN Position: Q3 2023 in Review
Clearview Wealth Advisors sold out of Amgen (AMGN) in Q3 2023, closing a stake of 22 shares — an estimated $4.88K sold.
Clearview Wealth Advisors first reported a position in AMGN in Q4 2020 and held it in 11 quarters. The position peaked at $433K in Q1 2021. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q3 2023.
- Clearview Wealth Advisors reported no remaining Amgen position as of Q3 2023 after selling out during the quarter.
- Clearview Wealth Advisors sold 22 Amgen shares in Q3 2023, an estimated $4.88K.
- Clearview Wealth Advisors first reported a position in Amgen in Q4 2020 and held it in 11 quarters.
- Clearview Wealth Advisors's Amgen position peaked at $433K in Q1 2021.
- 2,501 funds tracked by Wall St. Rank held Amgen as of Q3 2023.
Based on Clearview Wealth Advisors's 13F filing for Q3 2023, filed 30 Oct 2023.